Work

From immunomodulators (IMiDs) to cereblon E3 ligase modulator (CELMoDs): the evolution of cereblon modulators in lymphoma therapy

Year: 2026

Type: article

Source: Leukemia & lymphoma/Leukemia and lymphoma

DOI: 10.1080/10428194.2026.2662494

Authors: Aditi Saha, Khushali Jhaveri, Guilherme F. Perini, Julio C. Chavez

Institutions: University of Alabama at Birmingham, Indiana University School of Medicine, Hospital Israelita Albert Einstein, Mayo Clinic

Language: English

Topic: Protein Degradation and Inhibitors

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7161642965

FWCI:

Cites: 59

Cited by:

Related to: